333(g)(1) ), as added by subsection (a). Such regulations shall include provisions setting forth— (1) a reasonable amount of time a manufacturer has to update any direct-to-consumer advertising of a drug in accordance with such subparagraph (B) after a change to the wholesale acquisition cost of the drug